|
|
 | | | |
- close
- close
- close
- close
Orexo (STO:ORX) |
Benzinga
Mar 18
Comment
Galena Biopharma (NASDAQ: GALE) today announced it has entered into an agreement with Orexo AB (ORX.ST), an emerging specialty pharmaceutical company based in Sweden, to acquire Abstral® (fentanyl) Sublingual Tablets for sale and distribution in...
FierceBiotech
Jan 25
Comment
AstraZeneca CEO Pascal Soriot is banking on a deep pipeline of respiratory meds to help revive the beleaguered drug giant. On the early-stage front, the London-based pharma company has agreed to evaluate preclinical compounds for breathing...
FierceBiotech
Oct 27
Comment
> Transdel Pharmaceuticals has appointed John Bonfiglio as CEO and president. Bonfiglio will also serve as a director on Transdel's board of directors. Transdel release
> PharmAthene has appointed Eric Richman to the position of oresident and...
FierceBiotech
Aug 11
Comment
Signum Biosciences has appointed Braham Shroot, formerly CSO of Barrier Therapeutics, as CEO. Shroot replaces Gregory Stock, who will continue to remain active with the company as a member of the board. Signum release
Renhuang Pharmaceuticals...
FierceBiotech
Jun 2
Comment
Sweden's Orexo is pocketing $10 million from an upfront payment it will reap as part of a three-year, $585 million development pact with J&J's drug arm. The collaboration centers on preclinical small molecule drug candidates Orexo has been...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
